Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 594,697
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $56,737,885
Total People Sold 5 5 6 7
Total Sell Transactions 11 15 24 53
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 1313
  Page 5 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2023-03-16 4 D $93.41 $1,915,839 D/D (20,510) 65,486     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2023-03-15 4 D $87.74 $265,414 D/D (3,025) 100,324     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2023-03-15 4 A $0.00 $0 D/D 8,900 103,349     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-03-15 4 D $87.74 $828,002 D/D (9,437) 514,519     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-03-15 4 A $0.00 $0 D/D 36,100 523,956     -
   Guyer Charles Greg EVP, Chief Technical Officer   •       –      –    2023-03-15 4 D $87.74 $162,845 D/D (1,856) 49,464     -
   Guyer Charles Greg EVP, Chief Technical Officer   •       –      –    2023-03-15 4 A $0.00 $0 D/D 8,900 51,320     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2023-03-15 4 D $87.74 $421,064 D/D (4,799) 224,187     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2023-03-15 4 A $0.00 $0 D/D 16,840 228,986     -
   Burkhart Erin GVP, Chief Accounting Officer   •       –      –    2023-03-15 4 A $0.00 $0 D/D 3,760 14,890     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2023-03-15 4 D $87.74 $237,600 D/D (2,708) 59,558     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2023-03-15 4 A $0.00 $0 D/D 9,630 62,266     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2023-03-15 4 D $87.74 $348,416 D/D (3,971) 85,996     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2023-03-15 4 A $0.00 $0 D/D 10,110 89,967     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-03-13 4 AS $90.45 $723,600 D/D (8,000) 487,856     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-03-13 4 OE $67.81 $542,480 D/D 8,000 495,856     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-03-10 4 AS $92.28 $1,384,200 D/D (15,000) 487,856     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-03-10 4 OE $67.81 $1,017,150 D/D 15,000 502,856     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2023-02-28 4 A $0.00 $0 D/D 24,890 52,636     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-02-28 4 A $0.00 $0 D/D 167,532 487,856     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2023-02-28 4 A $0.00 $0 D/D 38,769 79,857     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2023-02-28 4 A $0.00 $0 D/D 68,052 212,146     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2023-02-28 4 A $0.00 $0 D/D 37,724 94,449     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2023-02-24 4 OE $67.81 $99,952 D/D 1,474 56,725     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-02-13 4 AS $109.15 $654,900 D/D (6,000) 320,324     -
  1313 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us